Learn More
OBJECTIVE We sought to examine several competing factor structures of the Beck Depression Inventory-II (BDI) in a sample of patients with End-Stage Renal Disease (ESRD), in which setting the factor structure is poorly defined, though depression symptoms are common. In addition, demographic and clinical correlates of the identified factors were examined. (More)
Sphingobacterium spiritivorum is a microorganism that is ubiquitously found in the environment. However, it is rarely isolated from human clinical specimens. There are few reports to date of Sphingobacterium spiritivorum causing disease in humans. We describe a case of Sphingobacterium spiritivorum infection in a patient on haemodialysis, which to our(More)
OBJECTIVES Patients with end-stage kidney disease receiving haemodialysis (HD) are at risk of cardiovascular disease and bone disorders related to high levels of serum phosphate. We studied the association between medication beliefs and depressive symptoms, with non-adherence to phosphate binding medication in a group of HD patients at risk of complications(More)
OBJECTIVE Haemodialysis patients are at risk of serious health complications; yet, treatment non-adherence remains high. Warnings about health risks associated with non-adherence may trigger defensive reactions. We studied whether an intervention based on self-affirmation theory reduced resistance to health-risk information and improved fluid treatment(More)
Intravenous white spirit injection is a rarely documented event that can cause potentially fatal respiratory collapse and abscess formation. A 40-year-old man was admitted from the emergency department with pleuritic chest pain. Severe anterior pain developed 10 min after the deliberate injection of 10 mL of white spirit intravenously into his left median(More)
Sir, A recent review of recombinant human erythropoietin (rHuEPO)-associated pure red cell aplasia (PRCA) cautioned re-challenge with the same or alternative rHuEPO products in the face of continued anaemia in patients with end-stage renal failure [1]. The mainstay of treatment should involve withdrawal of epoetin therapy, immunosup-pression and supportive(More)
  • 1